REG-Arix Bioscience PLC Total Voting Rights

Arix BioscienceAnnouncement

08/02/2022 07:25

============

   Arix Bioscience PLC (ARIX)
   Total Voting Rights

   08-Feb-2022 / 07:20 GMT/BST
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

                              Arix Bioscience plc

                                        

                              Total Voting Rights

   LONDON, 8  February 2022:  Arix Bioscience  plc announces that  its  total
   issued share capital at the close of business on 7 Februry 2022  comprised
   135,609,653 Ordinary Shares  of 0.001 pence each fully  paid. This  figure
   includes 6,428,853 Ordinary Shares which  are held in Treasury, leaving  a
   balance of 129,180,800 Ordinary Shares with voting rights.             

   The above  figure of  129,180,800  may be  used  by shareholders  for  the
   calculations by which they will determine  if they are required to  notify
   their major interest  in, or  a change  to their  major interest  in, Arix
   Bioscience plc under the Disclosure Guidance and Transparency Rules. 

    

                                      ENDS 

    

    

    

    

   For more information on Arix, please contact:

    

   Arix Bioscience plc

   +44 (0)20 7290 1050

    1 ir@arixbioscience.com

    

   Powerscourt Group

   Sarah MacLeod, Ibrahim Khalil

   +44 (0)20 7250 1446

    2 arix@powerscourt-group.com

    

    

    

    

   ══════════════════════════════════════════════════════════════════════════

   ISIN:           GB00BD045071
   Category Code:  TVR
   TIDM:           ARIX
   LEI Code:       213800OVT3AHQCXNIX43
   OAM Categories: 2.5. Total number of voting rights and capital
   Sequence No.:   141463
   EQS News ID:    1277660


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1277660&application_name=news&site_id=reuters8

References

   Visible links
   1. mailto:ir@arixbioscience.com
   2. mailto:arix@powerscourt-group.com


============